SCHEMBL1758976

SCHEMBL1758976

CCOC=Cc1cnc2cc(Br)ccc2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.34
TSHR P16473 2/20 0.34
ALDH1A1 P00352 4/20 0.34
MAPT P10636 3/20 0.34
GAA P10253 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
RAB9A P51151 2/20 0.33
PABPC1 P11940 1/20 0.33
MAPK1 P28482 2/20 0.33
RXFP1 Q9HBX9 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
HTT P42858 4/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2C19 P33261 2/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
CCNC P24863 1/20 0.31
CDK8 P49336 1/20 0.31
PDGFRB P09619 1/20 0.31
SLC2A1 P11166 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1758850 0.80 BACE1 (0.42) HPGDALDH1A1MAPTSMN1; SMN2RAB9A
SCHEMBL1574432 0.75 DYRK1A (0.32) PDGFRB
SCHEMBL1574430 0.75 DYRK1A (0.32) PDGFRB
SCHEMBL3457768 0.73
SCHEMBL3457769 0.73
SCHEMBL20810399 0.73 HTT (0.40) TSHRALDH1A1SMN1; SMN2RAB9APABPC1
SCHEMBL18614453 0.72 PABPC1 (0.41) HPGDALDH1A1MAPTPABPC1HTT
SCHEMBL15111402 0.69 MAPT (0.33) MAPT
SCHEMBL13226945 0.69 PABPC1 (0.41) HPGDTSHRALDH1A1MAPTPABPC1
SCHEMBL163368 0.67 SLC2A1 (0.42) HPGDTSHRALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499127-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-09-19 EP disclosed
EP-2499115-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-09-19 EP disclosed
WO-2011059887-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-19 WO disclosed
WO-2011059850-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-19 WO disclosed